Synapse

← Molecular Biomedicine

Papers in Molecular Biomedicine

Page 4 · newest first

  1. SEMA6A inhibits tumor progression and boosts anti-tumor immunity via blocking the ISG15/TGFβ axis in colorectal cancerMolecular Biomedicine · 2026
  2. B7 homolog 3-targeted CAR-T cells secreting EGFR T-cell engagers for improved control of glioblastoma progressionMolecular Biomedicine · 2026
  3. Loss of the ER-cargo protein CLN8 increases severity of acute pancreatitis and upregulates ER-stress and ER-phagyMolecular Biomedicine · 2026
  4. Zebrafish dspb-/- mutant as a model for non-dilated left ventricular cardiomyopathy: exploring cardiac dysfunction and exercise modulationMolecular Biomedicine · 2026
  5. TELO2-interacting protein 1 (TTI1), a novel Wnt/β-catenin target gene, decreases chemo-sensitivity in colorectal cancer by modulating DNA damage responsesMolecular Biomedicine · 2026
  6. Glymphatic system impairment in neurological disorders: potential mechanisms and therapeutic targetsMolecular Biomedicine · 2026
  7. Targeted neuronal reprogramming rescues memory and neural synchrony in Alzheimer’s diseaseMolecular Biomedicine · 2026
  8. Targeting the Calcineurin Homologous Protein 1 (CHP1)-Transmembrane Protein 87A (TMEM87A) mechanosensing complex: a druggable vulnerability in metastatic ovarian cancerMolecular Biomedicine · 2026
  9. Spotlight on cGAS-STING: role in disease pathogenesis and therapeutic potentialMolecular Biomedicine · 2026
  10. Metabolic reprogramming in fibrosis-related diseases: underlying mechanisms and therapeuticsMolecular Biomedicine · 2026
  11. Autophagy activation by urolithin-a derivative UA-36 mitigates Friedreich’s ataxia pathologies induced by frataxin deficiencyMolecular Biomedicine · 2026
  12. Exercise mimetics: molecular mechanisms, biological and therapeutic effectsMolecular Biomedicine · 2026
  13. CircRNA based bi-antigen vaccines against mpox virus induce potent and durable cross-protection in miceMolecular Biomedicine · 2026
  14. Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment optionsMolecular Biomedicine · 2026
  15. Unlocking the roles of plasma soluble T-cell immunoglobulin and mucin domain-containing protein 3 in kidney diseases: findings from native and allograft biopsy cohortsMolecular Biomedicine · 2026
  16. Mitochondrial dysfunction in neurodegenerative disorders: mechanisms and therapeutic advancesMolecular Biomedicine · 2026
  17. Neointimal hyperplasia and vascular restenosis: from molecular mechanisms to therapeutic interventionsMolecular Biomedicine · 2026
  18. Tissue factor promotes vascular invasion and metastasis in hepatocellular carcinoma via combined activation of β-catenin/STAT3 signalingMolecular Biomedicine · 2026
  19. Noninvasive detection and prognostic stratification of biliary tract cancer using cell-free DNA fragmentomics: a model development and validation studyMolecular Biomedicine · 2026
  20. Lactate and lactylation: mechanisms, function, diseases, and therapeutic targetsMolecular Biomedicine · 2026
  21. RPRD1A drives lenvatinib resistance in hepatocellular carcinoma via the ITGA5-FAK signaling axisMolecular Biomedicine · 2026
  22. Intratumoral microbiota in cancer: molecular mechanism and therapeutic strategiesMolecular Biomedicine · 2026
  23. Superparamagnetic iron oxide nanoparticle-driven 3-aroyl-1,4-diarylpyrrole nanocomposites (ARDAP@SPION-PEI) mediate renal cancer cell PANoptosis by regulating chromatin accessibilityMolecular Biomedicine · 2026
  24. Melatonin targets mitochondrial trifunctional enzyme HADHA to improve lipid metabolism in metabolic dysfunction-associated steatotic liver diseaseMolecular Biomedicine · 2026
  25. Modulation of the immunogenic landscape in colorectal cancer by mitochondrial methylation-controlled J proteinMolecular Biomedicine · 2026
  26. Transition from acute kidney injury to chronic kidney disease: molecular mechanisms and therapeutic interventionsMolecular Biomedicine · 2026
  27. Extracellular cGAMP in health and diseaseMolecular Biomedicine · 2026
  28. Molecular characteristics, clonal relatedness and surgical outcomes of pulmonary mixed invasive mucinous and non-mucinous adenocarcinoma: a retrospective cohort studyMolecular Biomedicine · 2026
  29. The m6A reader IGF2BP2 promotes hepatocellular carcinoma progression via enhancing RELB stabilityMolecular Biomedicine · 2026
  30. Glioblastoma: epidemiology, molecular pathogenesis, diagnosis, management, and therapeutic resistanceMolecular Biomedicine · 2026
  31. Correction: UCHL5 is a putative prognostic marker in renal cell carcinoma: a study of UCHL familyMolecular Biomedicine · 2026
  32. Subarachnoid hemorrhage: epidemiology, risk factors, pathogenesis, and clinical therapiesMolecular Biomedicine · 2026
  33. PFKP is required for chemoresistant phenotype of breast cancer through modulating the formation of CD133+ cancer stem like cellsMolecular Biomedicine · 2026
  34. DNA and RNA editing for the therapy of human diseases: current status, challenges, and future prospectsMolecular Biomedicine · 2026
  35. In vivo CAR-cell therapy: current challenges and emerging therapeutic advancesMolecular Biomedicine · 2026
  36. Lactate-driven pyrimidine synthesis promotes ferroptosis resistance in hepatocellular carcinomaMolecular Biomedicine · 2026
  37. The tumor suppressor NDRG2 promotes ACC1 proteasomal degradation and inhibits de novo lipogenesis in hepatocellular carcinomaMolecular Biomedicine · 2026
  38. Impact of Ser81 phosphorylation on alanine: glyoxylate aminotransferase associated with Primary hyperoxaluria type IMolecular Biomedicine · 2026
  39. Amelioration of acute liver failure by a cinnamic acid derivative through inhibition of the ROS–NETosis axisMolecular Biomedicine · 2026
  40. Machine learning integrated clinical-proteomics data identifies a 6-protein panel signature for atherosclerotic severity and enhanced patient stratificationMolecular Biomedicine · 2026
  41. Targeting ANXA1/TRKA axis enhances immunotherapy sensitivity in neural invasion-positive gastric cancerMolecular Biomedicine · 2026
  42. High-linear energy transfer radiation disrupts natural killer cell surveillance of senescent intestinal cells in the mouse intestineMolecular Biomedicine · 2026
  43. Targeting the RNA-binding motif protein 15 suppresses prostate cancer progression and hormone therapy resistance by promoting androgen receptor degradationMolecular Biomedicine · 2026
  44. Parkinson's disease: pathogenesis and therapeutic strategiesMolecular Biomedicine · 2026
  45. Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomasMolecular Biomedicine · 2026
  46. Chaperonin in health and diseaseMolecular Biomedicine · 2026
  47. Alzheimer's disease: from molecular pathways to therapiesMolecular Biomedicine · 2026
  48. Cancer and aging: complex associations and therapeutic targetsMolecular Biomedicine · 2026
  49. Astrocytes in neuroinflammation and brain cancerMolecular Biomedicine · 2026
  50. YTH N6-methyladenosine RNA binding protein 2 mediated m6A modification of circHIPK2 promotes cellular senescence and osteoarthritis progression by inhibiting autophagyMolecular Biomedicine · 2026